Maynard Nexsen is pleased to announce Christin Carey has joined the firm as a Shareholder in its Health Care & Life Sciences Practice Group, bringing more than a decade of experience advising life sciences and technology companies on complex regulatory, compliance, and product development matters.

Christin focuses her practice on U.S. Food and Drug Administration (FDA) regulation of medical devices, digital health technologies, software-based interventions, and pharmaceutical products. Drawing on experience in both private practice and in-house roles, Christin provides practical, business-minded counsel to clients operating in rapidly changing and often ambiguous regulatory environments.

Meet Life Sciences Attorney Christin Carey